Ipca Laboratories Ltd

BSE Code : 524494
NSE Symbol : IPCALAB
ISIN : INE571A01038
Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

Trade Now

Get Quotes

1,389.80 58.10(4.36%)

Open Price (₹)

1,344.50

Prev. Close (₹)

1,331.70

Volume (No’s)

335,012

Market Cap (₹)

33,785.79

Low Price (₹)

1,331.70

High Price (₹)

1,397.00

Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Profit and Loss

	Mar 2024 (₹.Cr)	Mar 2023 (₹.Cr)	Mar 2022 (₹.Cr)	Mar 2021 (₹.Cr)	Mar 2020 (₹.Cr)	Mar 2019 (₹.Cr)
INCOME :
Sales Turnover	6,166.46	5,814.62	5,438.30	5,139.16	4,367.43	3,633.15
Excise Duty	0.00	0.00	0.00	0.00	29.61	27.49
Net Sales	6,166.46	5,814.62	5,438.30	5,139.16	4,337.82	3,605.66
Other Income	111.29	111.19	52.92	62.24	64.69	54.59
Stock Adjustments	55.19	-104.09	126.00	170.73	155.05	106.14
Total Income	6,332.94	5,821.72	5,617.22	5,372.13	4,557.56	3,766.39
EXPENDITURE :
Raw Materials	2,033.57	1,964.94	1,911.88	1,753.21	1,635.75	1,265.89
Power & Fuel Cost	253.33	277.21	237.44	201.48	196.82	175.25
Employee Cost	1,336.19	1,193.39	1,102.14	948.84	870.79	752.24
Other Manufacturing Expenses	356.81	311.74	279.03	225.25	198.30	168.78
Selling & Administrative Expenses	846.95	812.67	612.89	551.23	523.99	511.56
Miscellaneous Expenses	314.87	236.31	179.67	113.31	149.41	142.31
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	5,141.72	4,796.26	4,323.05	3,793.32	3,575.06	3,016.03
Operating Profit	1,191.22	1,025.46	1,294.17	1,578.81	982.50	750.36
Interest	122.58	46.34	10.41	11.13	18.84	21.09
Gross Profit	1,068.64	979.12	1,283.76	1,567.68	963.66	729.27
Depreciation	246.48	228.63	209.65	187.72	178.69	171.88
Profit Before Tax	822.16	750.49	1,074.11	1,379.96	784.97	557.39
Tax	288.01	223.95	197.28	244.98	137.98	102.48
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	3.74	20.84	16.46	-5.79	-5.47	0.00
Reported Net Profit	530.41	505.70	860.37	1,140.77	652.46	454.91
Extraordinary Items	-69.52	17.51	7.86	8.34	10.86	6.30
Adjusted Net Profit	599.93	488.19	852.51	1,132.43	641.60	448.61
Adjustment below Net Profit	-1.39	-2.05	1.15	-0.16	-107.04	-1.10
P & L Balance brought forward	4,478.52	4,076.35	3,316.31	2,277.18	1,752.53	1,311.36
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	50.74	101.48	101.48	101.48	20.77	12.64
P & L Balance carried down	4,956.80	4,478.52	4,076.35	3,316.31	2,277.18	1,752.53
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	400.00	400.00	400.00	400.00	250.00	150.00
Dividend Per Share(Rs)	4.00	4.00	4.00	8.00	5.00	3.00
Earnings Per Share-Unit Curr	20.91	19.93	33.91	89.93	51.64	36.00
Earnings Per Share(Adj)-Unit Curr	20.91	19.93	33.91	44.97	25.82	18.00
Book Value-Unit Curr	250.24	231.66	215.84	374.67	290.11	248.25
Book Value(Adj)-Unit Curr	250.24	231.66	215.84	187.34	145.06	124.13